Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Popular prostate cancer treatment associated with bone decay

  • - Urology / Nephrology News
  • Oct 10, 2010
  • Comments
  • Viewed: 3402
  
Tags: | adt | androgen deprivation therapy | bone decay | computed tomography |

Using novel technology allowing “virtual bone biopsies” researchers have found that a common treatment for prostate cancer called androgen deprivation therapy (ADT) is associated with structural decay of cortical and trabecular bone. The study has been accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).

Prostate cancer is the second most common cancer in men worldwide and estimates suggest there are currently 600,000 men in the United States with the condition who are being treated with ADT. Prostate cancer relies upon male hormones for its growth and ADT is a common treatment because it suppresses or blocks the production or action of male sex hormones. This is the first study to examine changes in bone structure during ADT.

“We used a new technology that allows us to assess bone microarchitecture and we found ADT is associated with structural decay of corticol (hard outer shell) and trabecular (spongy inner mesh) bone,” said Emma Hamilton, MBBS and Mathis Grossmann, MD, PhD, of the University of Melbourne in Australia and lead authors of the study. “This technology may be a useful test in predicting fractures in patients, but further research is needed in identifying individuals at greatest fracture risk as well as optimal therapeutic strategies.”

In this study, researchers conducted a 12 month prospective observational study of 26 men with prostate cancer who began ADT. At several points during the study, measurements were taken for sex steroid levels, bone turnover markers and bone mineral density. Furthermore, researchers used three-dimensional high resolution peripheral quantitative computed tomography (HR-pQCT) to assess bone microarchitecture. This technology allows researchers to take virtual bone biopsies, according to Grossmann.

“Sex steroid deficiency induced by ADT for prostate cancer results in microarchitectural decay,” said Grossmann. “Bone fragility in these men may be more closely linked to testosterone than estradiol deficiency.”

###

Other researchers working on the study include: A. Ghasem-Zadeh, E. Gianatti, D. Lim-Joon, D. Bolton, R. Zebaze, E. Seeman and J.D. Zajac of the University of Melbourne in Australia.

The article, “Structural Decay of Bone Microarchitecture in Men with Prostate Cancer treated with Androgen Deprivation Therapy,” will appear in the December 2010 issue of JCEM.

Founded in 1916, The Endocrine Society is the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society’s membership consists of over 14,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at http://www.endo-society.org.

###
Contact: Aaron Lohr
.(JavaScript must be enabled to view this email address)
240-482-1380
The Endocrine Society

Bookmark and Share

Post a comment [ + Comment here + ]

There are no comments for this entry yet. [ + Comment here + ]




Comment
Your details

* Required field


Please enter the word you see in the image below:

Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.

renal replacement treatment1 - prunus africana1 - severe kyphoscoliosis1 - systems biology1 - liver transplant1 - blood test4 - cancer treatment3 - immunologic mechanisms1 - physicians1 - reiter's syndrome2 - urodynamics1 - demeclocycline1 - cardiovascular mortality1 - ufm1 - embryonic urothelium1 - metastatic cancer1 - department of urology2 - oligospermia1 - heart dysfunction1 - bladder ulcer1 - neurological disorders1 - urethral pain1 - short-term hormone therapy1 - glomerular filtration rate4 - iliococcygeus1 - differential diagnosis1 - uterine fibroids1 - nvasive follow-up tests1 - trichomoniasis1 - triage1 -